Publications by authors named "Benoit Blanchet"

Claim this Profile
L
LC-MS/MS method for quantification of avacopan in human plasma from patients treated for antineutrophil cytoplasmic antibody-associated vasculitis.
Juliette Blondel, Léo Froelicher-Bournaud, Stanislas Faguer, Jean Philippe Coindre, Benjamin Terrier, Benoit Blanchet

J Pharm Biomed Anal· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining Optimally Safe and Effective Blood Levels of Hydroxychloroquine in Lupus: An Important Step toward Precision Drug Monitoring.
Shivani Garg, Benoît Blanchet, Yann Nguyen, Fauzia Hollnagel, Ada Clarke

Arthritis Rheumatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of rituximab induction and maintenance regimens in anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: PK/PD modelling of ANCA and gammaglobulin levels in real-world patients.
Blaise Pasquiers, Benoit Blanchet, Xavier Puéchal, Xavier Declèves, Pascal Cohen

EBioMedicine· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with medication adherence trajectory among patients treated with oral anticancer drugs: a multicentre cohort study.
Germain Perrin, Audrey Thomas-Schoemann, François Goldwasser, Pascaline Boudou-Rouquette, Nicolas Delanoy, Benoit Blanchet

Support Care Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Droplet Digital PCR Assay for Detection and Monitoring of Universally Methylated ctDNA in Patients with Sarcoma.
Elisabeth Ashton, Valérie Taly, Camille Tlemsani, Pascaline Boudou-Rouquette, Sixtine de Percin, Benoit Blanchet

Clin Cancer Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and economic impact of pharmacist interventions to identify drug-related problems in multidisciplinary cancer care: a prospective trial.
Jean-Stéphane Giraud, Virginie Korb-Savoldelli, Germain Perrin, Anne Jouinot, Brigitte Sabatier, Benoit Blanchet

Oncologist· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydroxychloroquine levels in pregnancy and materno-fetal outcomes in systemic lupus erythematosus patients.
Gelsomina Alle, Gaëlle Guettrot-Imbert, Maddalena Larosa, Anne Murarasu, Estibaliz Lazaro, Benoit Blanchet

Rheumatology (Oxford)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter to the editor regarding the paper by A. Boileve et al.: Safety of direct oral anticoagulants in patients with advanced solid tumors receiving anti‑VEGF agents: a retrospective study.
Tinhinane Inouri, Johanna Noel, Benoît Blanchet, Audrey Thomas-Schoemann

Support Care Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intra-individual Dose Escalation of Abiraterone According to Its Plasma Exposure in Patients with Progressive Metastatic Castration-Resistant Prostate Cancer: Results of the OPTIMABI Trial.
Jérôme Alexandre, Stephane Oudard, Lisa Golmard, Luca Campedel, Mourad Mseddi, Benoit Blanchet

Clin Pharmacokinet· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extending the dosing intervals of nivolumab: model-based simulations in unselected cancer patients.
Alicja Puszkiel, Guillaume Bianconi, Blaise Pasquiers, David Balakirouchenane, Jennifer Arrondeau, Benoit Blanchet

Br J Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care.
Benoit Blanchet, Alexandre Xu-Vuilard, Anne Jouinot, Florent Puisset, David Combarel

Br J Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving olaparib exposure to optimize adverse effects management.
Marylise Sterlé, Alicja Puszkiel, Chloé Burlot, Eva Pereira, Audrey Bellesoeur, Benoit Blanchet

Ther Adv Med Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pazopanib pharmacokinetically guided dose optimization in three cancer patients with gastrointestinal resection.
Cléa Tardy, Alicja Puszkiel, Pascaline Boudou-Rouquette, Sixtine De Percin, Jérôme Alexandre, Benoit Blanchet

Cancer Chemother Pharmacol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potential of microbiota information to better predict efficiency traits in growing pigs fed a conventional and a high-fiber diet.
Vanille Déru, Francesco Tiezzi, Céline Carillier-Jacquin, Benoit Blanchet, Laurent Cauquil

Genet Sel Evol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Severe Nonadherence to Hydroxychloroquine and Systemic Lupus Erythematosus Flares, Damage, and Mortality in 660 Patients From the SLICC Inception Cohort.
Yann Nguyen, Benoît Blanchet, Murray B Urowitz, John G Hanly, Caroline Gordon

Arthritis Rheumatol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Plasma Rituximab Concentration and the Risk of Major Relapse in Antineutrophil Cytoplasmic Antibody-Associated Vasculitides During Rituximab Maintenance Therapy.
Nihel Khoudour, Florence Delestre, Fabienne Jabot-Hanin, Anne Jouinot, Juliette Nectoux, Benoit Blanchet

Arthritis Rheumatol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics/Pharmacodynamics of Dabrafenib and Trametinib for Redifferentiation and Treatment of Radioactive Iodine-Resistant Mutated Advanced Differentiated Thyroid Cancer.
David Balakirouchenane, Romain Seban, Lionel Groussin, Alicja Puszkiel, Anne Ségolène Cottereau, Benoît Blanchet

Thyroid· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydroxychloroquine sulfate: A novel treatment for lipin-1 deficiency?
Perrine Renard, Laure Caccavelli, Antoine Legendre, Caroline Tuchmann-Durand, David Balakirouchenane, Benoit Blanchet

Biomed Pharmacother· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LC-MS/MS method for simultaneous quantification of osilodrostat and metyrapone in human plasma from patients treated for Cushing's Syndrome.
David Balakirouchenane, Axelle Vasseur, Fidéline Bonnet-Serrano, Minna Choi, Nihel Khoudour, Benoit Blanchet

J Pharm Biomed Anal· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive factors associated with pemetrexed acute toxicity.
Mathilde Bonnet, Anne Jouinot, Pascaline Boudou-Rouquette, Vanessa Seif, Clémentine Villeminey, Benoit Blanchet

Eur J Clin Pharmacol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac toxicity associated with pharmacokinetic drug-drug interaction between crizotinib and sofosbuvir/velpatasvir: A case report.
Anthia Monribot, Olivier Huillard, Nihel Khoudour, Laure-Hélène Préta, Benoit Blanchet

Br J Clin Pharmacol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High plasma concentrations of acyl-coenzyme A binding protein (ACBP) predispose to cardiovascular disease: Evidence for a phylogenetically conserved proaging function of ACBP.
Léa Montégut, Adrien Joseph, Hui Chen, Mahmoud Abdellatif, Christoph Ruckenstuhl, Benoit Blanchet

Aging Cell· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors in the Treatment of Advanced Renal Cancer.
Florent Puisset, Mourad Mseddi, Loïc Mourey, Damien Pouessel, Benoit Blanchet

Cancers (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure-Response Analysis of Osimertinib in Patients with Advanced Non-Small-Cell Lung Cancer.
Thomas Rodier, Alicja Puszkiel, Evelina Cardoso, David Balakirouchenane, Céline Narjoz, Benoit Blanchet

Pharmaceutics· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring of Dabrafenib and Trametinib in Serum and Self-Sampled Capillary Blood in Patients with BRAFV600-Mutant Melanoma.
Nora Isberner, Anja Gesierich, David Balakirouchenane, Bastian Schilling, Fatemeh Aghai-Trommeschlaeger, Benoit Blanchet

Cancers (Basel)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis